MEDIFAST INC (MED)
NYSE: MEDConsumer StaplesPackaged FoodsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MED stock chart
Technical analysisKey statistics
All statistics- Market cap
- $131.40M
- EPS (TTM)
- -$3.70
- Dividend yield
- None
- Ex-dividend date
- Sep 18, 2023
- 52-week range
- 9.22 – 13.63
- Day range
- 11.32 – 11.98
- Volume / Avg
- 177.76K / 122.13K
- Beta
- —
- Shares outstanding
- 11.18M
52-week range
MED stock today
MEDIFAST INC (MED) closed at $11.75 on Nov 20, down 1.92% (-$0.23), versus the S&P 500's 3.70% decline. At this level, MED sits in the middle of its 52-week range of $9.22 to $13.63: 13.8% below the high, set on Nov 9, 2026 and 27.4% above the low. MED is up 10.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 10.0%.
MEDIFAST INC has posted a net loss over the last twelve months (EPS of -$3.70), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About MEDIFAST INC
Company profileMedifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss.
- Sector
- Consumer Staples
- Industry
- Packaged Foods
- CEO
- Mr. Nicholas M. Johnson
- Headquarters
- Baltimore, MD
- Employees
- 380
- Website
- medifastinc.com
Financial highlights
Full financialsIn fiscal 2025, MEDIFAST INC generated $385.8 million in revenue, down 36.0% from fiscal 2024, its first annual decline since 2024. MEDIFAST INC reported a net loss of $18.7 million, compared with net income of $2.1 million a year earlier. Gross margin was 71.3% (down from 73.8%) and operating margin -3.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $385.79M | $602.46M | $1.07B | $1.60B | $1.53B |
| Growth | -35.96% | -43.80% | -32.94% | +4.75% | +63.25% |
| Net income | $-18.67M | $2.09M | $99.42M | $143.57M | $164.03M |
| EPS (diluted) | $-1.70 | $0.19 | $9.10 | $12.73 | $13.89 |
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$12.00+2.13%
- Strong buy 0
- Buy 0
- Hold 1
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 26, 2026
- EPS actual vs est.
- $-1.57 vs $-0.40
- Surprise
- -292.50%
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $1.65
- Ex-dividend date
- Sep 18, 2023
MED news
All MED news- Can Medifast's Coaching Model Complement GLP-1 Weight-Loss Drugs?NasdaqMED, SJM, BGS, LW
- Will Medifast's Metabolic Health Institute Strengthen Its Edge?NasdaqMED, SJM, LW
- Medifast: 3 Key Takeaways for Long-Term InvestorsNasdaqMED, UHAL.B
- Medifast (MED) Q3 2026 Earnings Call TranscriptNasdaq
- Medifast, Inc. Reports Third Quarter 2026 Revenue of $72.0 millionNasdaq
- Medifast Q3 Loss Widens, Sees Profit In Q4, Loss In FY26; Shares UpNasdaq
- Medifast Announces Third Quarter 2026 Financial ResultsBusiness Wire
- Medifast Q3 Earnings on the Horizon: Key Insights for InvestorsNasdaqMED, HSY, FRPT, SYY
MEDIFAST INC peers
Consumer Staples sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BYNDBeyond Meat Inc. | 3.80 | -15.18% | $71.27M | vs MED |
| SOWGSow Good Inc. | 2.37 | +3.95% | $47.64M | vs MED |
| OTLYOatly Group AB ADR | 6.94 | -3.28% | $221.31M | vs MED |
| BOFBranchOut Food Inc. | 1.77 | -3.02% | $34.67M | vs MED |
| BHSTBioHarvest Sciences Inc. | 1.30 | -1.52% | $29.47M | vs MED |
| JVACoffee Holding Co. Inc. | 4.93 | -2.18% | $28.14M | vs MED |
| LSFLaird Superfood Inc. | 2.15 | -0.46% | $24.20M | vs MED |
| BRLSBorealis Foods Inc. Class A | 0.70 | -4.11% | $15.02M | vs MED |
Indexes, lists and sector
MEDIFAST INC stock FAQ
What is MEDIFAST INC's stock price today?
MED last traded at $11.75 as of Nov 20, 4:00 PM EST, down 1.92% on the day. Prices are delayed at least 15 minutes.
Does MEDIFAST INC pay a dividend?
Yes. MEDIFAST INC pays $0.00 per share annually. The most recent dividend of $1.65 had an ex-dividend date of Sep 18, 2023.
Who is MEDIFAST INC's CEO?
Mr. Nicholas M. Johnson is the chief executive officer of MEDIFAST INC, which has about 380 employees.
What is the MED 52-week high?
The 52-week high for MED is $13.63 and the 52-week low is $9.22. The stock is currently 13.8% below its high.